Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis

M van Hage-Hamsten, E Johansson, A Roquet, C Peterson, Morgan Andersson, Lennart Greiff, S Vrtala, R Valenta, R Gronneberg

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis'. Together they form a unique fingerprint.

Medicine & Life Sciences